Skip to content
mapperlab
← Dashboard
Stock

GUTS

Fractyl Health, Inc.
Latest close $0.814 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
4
27 funds tracked
Ever held
8
Current + past
New this quarter
0
Exited this quarter
3

Marquee-fund ownership over time

May 15, 2024Feb 13, 2025Nov 13, 2025May 15, 2026
Now
4

This quarter's activity

New positions opened

None.

Positions exited

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Maverick Capital$7.15$0.81-89%
Renaissance Technologies re-entered$1.78$0.81-55%
Citadel Advisors re-entered$2.23$0.81-64%
Two Sigma Investments$0.39$0.81+105%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
D.E. Shaw→ $0.86-32%
Millennium Management 2× in & out→ $0.86-48%
Point72 Asset Management→ $0.86-32%
AQR Capital Management→ $1.26-24%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at FRACTYL HEALTH, INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
1
Filings · last 90d
1
Total on file
53
Recent SEC buffer
Most recent
Jun 9, 2026

30d / 90d windows measured from Jun 9, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 53 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · Fractyl Health, Inc.

Annual figures sourced directly from Fractyl Health, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$0
FY2025-100% YoY
Net income
-$140.95M
FY2025-105% YoY
EPS (diluted)
$-1.86
FY2025-15% YoY
Free cash flow(?)
-$90.89M
FY2025-35% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for FRACTYL HEALTH, INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Two Sigma InvestmentsQ1 2026open$0.39$0.81+105%
Citadel AdvisorsQ4 2025open$1.26$0.81-36%
D.E. ShawQ4 2025Q2 2026$1.26$0.86-32%
Point72 Asset ManagementQ4 2025Q2 2026$1.26$0.86-32%
Renaissance TechnologiesQ4 2025open$1.12$0.81-28%
AQR Capital ManagementQ2 2025Q4 2025$1.65$1.26-24%
Millennium ManagementQ2 2025Q2 2026$1.65$0.86-48%
Citadel AdvisorsQ3 2024Q3 2025$2.23$0.98-56%
Millennium ManagementQ3 2024Q1 2025$2.23$1.58-29%
Renaissance TechnologiesQ3 2024Q1 2025$1.78$1.66-7%
Maverick CapitalQ2 2024open$7.15$0.80-89%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.